Literature DB >> 16609965

Expression of the angiomatrix and angiogenic proteins CYR61, CTGF, and VEGF in osteonecrosis of the femoral head.

S Radke1, A Battmann, S Jatzke, J Eulert, F Jakob, N Schütze.   

Abstract

Angiogenesis and bone repair are closely linked processes. VEGF, CYR61, and CTGF have been identified as signaling factors that control angiogenesis and could be important in fracture healing. The purpose of this study was to investigate the expression of these signaling factors in osteonecrosis of the femoral head. Twenty-one bone cylinders were retrieved from hips of patients with osteonecrosis of the femoral head at different ARCO stages. Immunohistochemistry for CD34, CYR61, CTGF, and VEGF expression was done on each bone cylinder representing the different regions of osteonecrosis (necrosis, fibrosis, transition zone, and edematous area). VEGF, CYR61, and CTGF were expressed in samples with osteonecrosis. Particularly VEGF and CYR61 were highly expressed in the edematous area. CYR61 was also highly expressed in the transition zone. CTGF was expressed mainly in the area of marrow fibrosis and edema. CYR61, CTGF, and VEGF are expressed to different degrees in the different repair zones of osteonecrosis. Particularly, the high expression of VEGF and CYR61 in the edematous area may represent a consequence of hypoxia and indicate a role of these proteins in the repair processes ongoing in osteonecrosis. Copyright 2006 Orthopaedic Research Society.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16609965     DOI: 10.1002/jor.20097

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  10 in total

1.  Genetic association of angiogenesis- and hypoxia-related gene polymorphisms with osteonecrosis of the femoral head.

Authors:  Jung Min Hong; Tae Ho Kim; Hyun Ju Kim; Eui Kyun Park; Eun Kyoung Yang; Shin Yoon Kim
Journal:  Exp Mol Med       Date:  2010-05-31       Impact factor: 8.718

Review 2.  Bone marrow lesions: a universal bone response to injury?

Authors:  Erik Fink Eriksen; Johan Diederich Ringe
Journal:  Rheumatol Int       Date:  2011-09-08       Impact factor: 2.631

3.  Imbalanced bone turnover markers and low bone mineral density in patients with osteonecrosis of the femoral head.

Authors:  Lulu Tian; Seung-Hoon Baek; JinAn Jang; Shin-Yoon Kim
Journal:  Int Orthop       Date:  2018-03-27       Impact factor: 3.075

Review 4.  Hypoxia Signaling in the Skeleton: Implications for Bone Health.

Authors:  Clare E Yellowley; Damian C Genetos
Journal:  Curr Osteoporos Rep       Date:  2019-02       Impact factor: 5.096

5.  The association between VEGF -634C/G polymorphisms and osteonecrosis of femoral head: a meta-analysis.

Authors:  Yao Wang; Chong-Jun Xia; Beng-Jie Wang; Xiao-Wei Ma; De-Wei Zhao
Journal:  Int J Clin Exp Med       Date:  2015-06-15

6.  Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing.

Authors:  Athanasios N Athanasopoulos; Darius Schneider; Tanja Keiper; Volker Alt; Usha R Pendurthi; Ute M Liegibel; Ulrike Sommer; Peter P Nawroth; Christian Kasperk; Triantafyllos Chavakis
Journal:  J Biol Chem       Date:  2007-07-10       Impact factor: 5.157

7.  Histological characteristics of the human femoral head in patients with femoral neck fracture.

Authors:  Takashi Sakai; Daiki Iwana; Nobuo Nakamura; Takashi Nishii; Masaki Takao; Tetsu Watanabe; Hideki Yoshikawa; Nobuhiko Sugano
Journal:  Virchows Arch       Date:  2012-10-20       Impact factor: 4.064

8.  Association between MMP-3 polymorphisms among Chinese patients with osteonecrosis of the femoral head.

Authors:  Yuxin Qi; Yong Zhu; Yuju Cao; Huiqiang Wu; Mingqi Sun; Hao Wu; Linlin Pan; Guoqiang Wang; Jianzhong Wang
Journal:  Oncotarget       Date:  2017-11-06

9.  Bone morphogenetic protein-2 exhibits therapeutic benefits for osteonecrosis of the femoral head through induction of cartilage and bone cells.

Authors:  Chunhui Wang; Huimei Zang; Dongsheng Zhou
Journal:  Exp Ther Med       Date:  2018-03-09       Impact factor: 2.447

10.  The Use of Platelet-Rich Plasma for the Treatment of Osteonecrosis of the Femoral Head: A Systematic Review.

Authors:  Jun Han; Fuqiang Gao; Yajia Li; Jinhui Ma; Wei Sun; Lijun Shi; Xinjie Wu; Tengqi Li
Journal:  Biomed Res Int       Date:  2020-03-07       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.